
SAR125884
CAS No. 1116743-46-4
SAR125884( —— )
Catalog No. M20207 CAS No. 1116743-46-4
SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 106 | In Stock |
![]() ![]() |
25MG | 215 | In Stock |
![]() ![]() |
50MG | 345 | In Stock |
![]() ![]() |
100MG | 560 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSAR125884
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).
-
DescriptionSAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).
-
In VitroCell Proliferation Assay Cell Line:H-460 cells, HCT116 cells, H1993 cells, EBC-1 cells, SNU-5 cells, OE33 cells, Hs 746T cells and MKN-45 cellsConcentration:1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1000 nM, 3000 nM, 10000 nMIncubation Time:96 hResult:Inhibited cell proliferation in all cell lines with MET gene amplification, with IC50 values in the nanomolar range (1-7 nM), with the exception of the lung cancer cell line NCI-H1573.Apoptosis Analysis Cell Line:SNU-5 cells Concentration:1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM Incubation Time:24 h, 48 h, 72 h Result:Induced massive apoptosis in SNU-5 cells at 48 and 72 hours, with a relative EC50 value of 6 nM and a plateau of 60% at 72 hours.Cell Migration Assay Cell Line:H-460 cells, HCT116 cells, H1993 cells, EBC-1 cells, SNU-5 cells, OE33 cells, Hs 746T cells and MKN-45 cells Concentration:3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1000 nMIncubation Time:20 h Result:Inhibited cell migration with an IC50 value of 26 nM。
-
In VivoAnimal Model:SNU-5 and Hs 746T tumor-bearing miceDosage:45 mg/kg Administration:Intravenous injection (i.v.)Result:Resulted in complete and almost complete tumor regression in 3 of 8 mice and 5 of 8 mice, respectively. Animal Model:MET-amplified gastric tumor model mice Dosage:5 mg/kg, 11 mg/kg, 21 mg/kg, 53 mg/kg, 106 mg/kg, 213 mg/kg Administration:Intravenous injection (i.v.)Result:Resulted complete tumor regression in 7 of 8 of mice at 53, 106, and 213 mg/kg and partial regression at 11 and 21 mg/kg.Showed more than 80% MET inhibition at all doses and maintained for 96 hours at 213 mg/kg, 72 hours at.106 mg/kg, and 48 hours at 53 mg/kg.Showed complete or near-complete regression (92%–99%) and maintained for 7 days at 106 mg/kg, and 48 hours at 53 mg/kg.
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorMET RTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1116743-46-4
-
Formula Weight550.63
-
Molecular FormulaC25H23FN8O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:45 mg/mL (81.72 mM)
-
SMILESFc1ccc(cc1)-c1ccc2nnc(Sc3ccc4nc(NC(=O)NCCN5CCOCC5)sc4c3)n2n1
-
Chemical Name1-(6-((6-(4-fluorophenyl)-[124]triazolo[43-b]pyridazin-3-yl)thio)benzo[d]thiazol-2-yl)-3-(2-morpholinoethyl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Egile C et al. The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer. Mol Cancer Ther. 2015 Feb;14(2):384-94.
molnova catalog



related products
-
AMG-337
AMG-337 is a potent and selective inhibitor of MET with biochemical IC50 of 1 nM; inhibits of HGF-mediated MET phosphorylation in PC3 cells.
-
SOMG-833
A potent, selective, ATP-competitive c-MET inhibitor with IC50 of 0.93 nM.
-
Tivantinib
Tivantinib (ARQ-197)?is a potent, selective, non-ATP-competitive inhibitor of c-Met with Ki of 355 nM.